AK130

· Akeso Biotherapeutics

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for AK130, covering 2024-08-13 to 2026-03-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study of AK130 in Combination With AK112 for the Treatment of Advanced Biliary Tract Cancer [Phase 1, Phase 2]